Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer

Clinical trial NCT01267253 · COMPLETED

Trial details

NCT number: NCT01267253
Sponsor: Gynecologic Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Persistent Disease Recurrent Cervical Carcinoma

Start date: 2011-04-04
Primary completion: 2014-02-28
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.